MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 200mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 200mg tablets (Milpharm Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 25mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 25mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 25mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 25mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 25mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 25mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 25mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 25mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 25mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 25mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 25mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 25mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 25mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 25mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 25mg tablets (Milpharm Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 2mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 50mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 50mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 50mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 50mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 50mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 50mg tablets (Milpharm Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.